반응형

UL 139

[Emergo, UL] Current State of UDI in Brazil: Review of RDC 591/2021 and RDC 884/2024

The Normative Instruction to announce the ANVISA UDI database, SIUD, is expected soonBackground on RDC 591/2021The National Health Surveillance Agency or ANVISA (Agência Nacional de Vigilância Sanitária) is the Brazilian regulatory agency responsible for the supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices. Recently, ANVISA enacted RDC 591/2021, whic..

뉴스 보고서 2025.07.15

[Emergo, UL] European Packaging Waste Legislation Repeals the Directive and Applies in Mid-2026

The European legislation on packaging waste (Regulation (EU) 2025/40) was adopted late last year (December 19, 2024) and published in the Official Journal of the European Union (OJEU) in January (January 22, 2025), repealing Directive 94/62/EC. Most provisions start to apply on August 12, 2026. Directive 94/62/EC was concise. Regulation 2025/40 has 188 recitals, 71 definitions, 71 articles, and ..

뉴스 보고서 2025.07.14

[Emergo, UL] Is it Too Bold to Refer to this as the Quarter of Data Accessibility?: Second Quarter 2025 Developments

We at Emergo by UL continue to monitor and share regulatory updates and news after the first quarter. We’ve divided the developments this quarter into three topics: regulatory data, quality management system (QMS) and medical device software (MDSW). If there is one theme, it is the influence of the International Medical Device Regulators Forum (IMDRF), Medical Device Single Audit Program (MDSAP)..

뉴스 보고서 2025.07.11

[Emergo, UL] Decoding MDCG 2025-6: Interplay between the MDR/IVDR and AIA

If guidance on medical device software (MDSW) were a series, we just got three episodes in one week. Kicking off the triple release was MDCG 2025-4, released on June 16, which tackled the safe deployment of medical device apps on digital platforms. On June 17, a revised MDCG 2019-11 version clarified the qualification and classification of software under MDR/IVDR and introduced the interplay wi..

뉴스 보고서 2025.07.03

[Emergo, UL] European Commission issues guidance on making safer apps available

In our daily lives and also in the medical field, patients and healthcare professionals are increasingly using apps. On June 16, the European Commission (EC) published “MDCG 2025-4 Guidance on the safe making available of medical device software (MDSW) apps on online platforms.” While the EC has published several pieces of guidance on MDSW already (our next update will be on the MDCG 2019-11 rev..

뉴스 보고서 2025.06.30

[Emergo, UL] European Revision of Primary Software Guidance (MDCG 2019-11 Revision 1): Small Changes, Meaningful Clarifications

On June 17, 2025 (one day following the release of MDCG 2025-4), the EU commission published a revision to MDCG 2019-11, Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 – MDR and Regulation (EU) 2017/746 – IVDR. While there are no substantive changes, several meaningful clarifications are worth mentioning. Refined scope to include AIThe term medical device ar..

뉴스 보고서 2025.06.27

[Emergo, UL] Mexican Regulator COFEPRIS Revises Equivalency Route to Expand Leveraging Options

For the evaluation of health supply registrations, Mexico’s Federal Commission for Protection of Sanitary Risks (COFEPRIS) released a new agreement for the equivalency requirements established in articles 167, 170, 177, 177 Bis 2, 179 and 180 of the Health Supplies Regulations and the technical evaluation procedures performed by COFEPRIS. In these cases, the COFEPRIS review is abbreviated.Equiva..

뉴스 보고서 2025.06.19
반응형